STAT
AUGUST 5, 2024
Federally funded research in science, technology, engineering, mathematics, and medicine (STEMM) is a crown jewel of American higher education that confers enormous benefits upon the U.S. and the world. The integrity of the processes by which funding decisions are made is critically important to the success of the enterprise and its support by the public who pay for this research.
PharmaVoice
AUGUST 5, 2024
Wilson, who founded UPenn’s gene therapy program three decades ago, will step down to start two new spinouts, Gemma Bio and Franklin Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
AUGUST 5, 2024
The Covid-19 pandemic underscored the importance of infectious disease doctors — but the field is still facing a shortage , with consequences for the health of communities across the U.S. Specialists spoke out about the impact of the shortage and potential solutions at a recent press briefing organized by the Infectious Diseases Society of America.
PharmaVoice
AUGUST 5, 2024
The company’s cell therapy recently showed positive results from a mid-stage trial.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
AUGUST 5, 2024
The national uninsured rate rose from 7.7% to 8.2% earlier this year, a result of states booting millions of Americans from their state Medicaid programs, according to new data from the Centers for Disease Control and Prevention. The 7.7% uninsured rate in 2023 was a record low at the time, but didn’t factor in any of the people who were losing their Medicaid coverage.
Pharmafile
AUGUST 5, 2024
Today, the Orthopaedics branch of Johnson & Johnson MedTech, DePuy Synthes, has announced that their surgical robotics system VELYS active has received 501k clearance from the US Food and Drug Administration (FDA). The post Johnson & Johnson’s MedTech announce orthopaedics receives 501K clearance from FDA for spinal robotics and navigation platform appeared first on Pharmafile.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
AUGUST 5, 2024
Learn how to effectively harmonise global content strategies with local needs in the pharmaceutical market. Understand the unique challenges in the life science industry and how to measure success with relevant KPIs.
STAT
AUGUST 5, 2024
Recovery from a cardiac-related hospitalization requires coordinated, timely care to prevent a return to the hospital for an avoidable readmission. A new study concludes that while the picture is getting brighter for all Medicare patients, persistent racial disparities are widening. Poorer and rural patients were also less likely to have prompt post-discharge visits to check on issues such as medication, a common contributor to readmission.
BioPharma Dive
AUGUST 5, 2024
For years, many manufacturers have assumed that pre-market physician education was not strictly necessary unless their brand was the first to market or had a novel mechanism of action. With the advent of precision medicine, however, ongoing disease state education has become increasingly critical.
STAT
AUGUST 5, 2024
Struggling to find new patients, BioMarin Pharmaceuticals on Monday said it would restrict sales of its gene therapy for hemophilia A to three countries where it is currently approved, including the United States — a restructuring intended to reduce costs and help the treatment become profitable by next year. The one-time treatment called Roctavian was approved in Europe in 2022 and in the U.S. in 2023.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Pharma Times
AUGUST 5, 2024
Bowel cancer, the third most common cancer type worldwide, is the second most common cause of cancer death
STAT
AUGUST 5, 2024
As an epidemiologist and physician, I’ve long been concerned about how health interventions for marginalized communities are evaluated. A new study explores that concern and offers some solutions for making cost-effectiveness analyses work for everyone. Many of my patients live in San Francisco’s Bayview neighborhood, which is disproportionately Black, cut off from the rest of the city by freeways, and has a toxic waste problem from a nearby shipyard.
The Pharmacist
AUGUST 5, 2024
Locums have reported an increase in community pharmacy contractors changing their terms after the contract has been agreed, the Pharmacists’ Defence Association (PDA) has said. And it has advised locums to screenshot their contract so that they have a record of what has been agreed. Paul Day, PDA director, told The Pharmacist that the issue […] The post Contractors ‘changing terms’ for locums after contract agreed appeared first on The Pharmacist.
STAT
AUGUST 5, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! Today, we discuss the maneuverings of two interesting women in biotech: Verily alum Amy Abernethy and 23andMe CEO Anne Wojcicki. Also, we explore the dangers of off-brand GLP-1s, and see FDA advisers vote in favor of a Niemann-Pick drug.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Express Pharma
AUGUST 5, 2024
Funding in the pharma and healthcare space plunged 49 per cent to $27.8 million in July 2024 from $55.4 million in July 2023. This is also an 84 per cent decline from the $183 million raised in June 2024. Most of the funding (78.9 per cent) in July 2024 came from early-stage investments. This was followed by seed stage rounds, which accounted for 21.1 per cent of the total funding.
STAT
AUGUST 5, 2024
Good morning, everyone, and welcome to another working week. We hope the weekend respite was invigorating and refreshing, because that oh-so familiar routine of online meetings, phone calls, and deadlines has returned. But you knew this would happen, yes? After all, the world, such as it is, continues to spin, albeit a bit wobbly at times. So perhaps we should give it a nudge in a better direction with a cup or three of stimulation.
The Pharmacist
AUGUST 5, 2024
Thousands of pharmacies are being forced to stop providing NHS and public health services amid increasing financial and operational pressures, new polling from Community Pharmacy England (CPE) has revealed. In a poll of pharmacy owners representing more than 2,100 pharmacies across England, the majority (96%) said they had stopped delivering locally commissioned services over the […] The post Pharmacies left with ‘no choice’ but to stop services appeared first on The Pharmacist.
Express Pharma
AUGUST 5, 2024
Supriya Lifescience announces the appointment of Dr Saloni Wagh as Managing Director, and Shivani Satish Wagh as the Joint Managing Director. While Dr Satish Waman Wagh takes on the role of Whole-time Director and Executive Chairman. Dr Saloni Wagh holds a PhD in Chemistry from the Faculty of Science, Pacific University, Udaipur, India. With over 10 years of experience in business operations and marketing, Dr Saloni has played an integral role in Supriya Lifescience’s success and growth, partic
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
pharmaphorum
AUGUST 5, 2024
Discover the latest updates and insights on Agency, Consultancy, and Investor trends in the Changing Faces May-June 2024 issue featuring key players like Hanover, Real Chemistry, EVERSANA, Box Bear, and more.
Outsourcing Pharma
AUGUST 5, 2024
In this Q&A, we delve into the collaboration between Skye Bioscience and Beacon Biosignals to enhance the evaluation of nimacimab, a promising treatment for obesity and its comorbid conditions, including obstructive sleep apnea (OSA).
pharmaphorum
AUGUST 5, 2024
uniQure sheds two-thirds of its staff as it refocuses around a leaner pipeline headed by Huntington's therapy AMT-130
Pharma Times
AUGUST 5, 2024
Head and neck cancer is currently recognised as the sixth most common cancer globally
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Outsourcing Pharma
AUGUST 5, 2024
In this Q&A, we delve into the collaboration between Skye Bioscience and Beacon Biosignals to enhance the evaluation of nimacimab, a promising treatment for obesity and its comorbid conditions, including obstructive sleep apnea (OSA).
Pharmaceutical Technology
AUGUST 5, 2024
The European Commission (EC) has granted orphan drug designation (ODD) for Amylyx Pharmaceuticals’ AMX0035 to treat Wolfram syndrome.
pharmaphorum
AUGUST 5, 2024
Exploring the role of pharmacy and self-care in the fight against fatty liver and disease progression Mike.
Express Pharma
AUGUST 5, 2024
Lupin announced that it has received approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Prednisolone Acetate Ophthalmic Suspension USP, 1 per cent to market a generic equivalent of Pred Forte Ophthalmic Suspension, 1 per cent, of AbbVie. Lupin was granted a Competitive Generic Therapy designation (CGT) for this product, and being the first approved applicant, Lupin is eligible for 180 days of CGT exclusivity.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The Pharmacist
AUGUST 5, 2024
The safe supply of medicines must be the ‘key priority’ for pharmacies as GPs take collective action this month, Community Pharmacy England (CPE) has urged. GP partners have started taking action this month that will see many practices ‘working-to-rule’ and only undertaking tasks included in their NHS contract. GPs also have a list of actions […] The post Safe supply of medicines ‘key priority’ during GP action appeared first on The Pharmacist.
pharmaphorum
AUGUST 5, 2024
At the start of this year, Bayer said there were two important trial readouts for the company to deliver near-term growth this year as it rebuilds its pipeline – and both have now delivered positive results in the space of a month.This morning, the German group revealed that mineralocorticoid receptor antagonist (MRA) Kerendia (finerenone) was able to reduce cardiovascular death and other heart failure events compared to placebo in the FINEARTS-HF trial.
BioPharma Dive
AUGUST 5, 2024
The decision makes Bristol the latest pharma to pull back on research into a type of cancer immunotherapy that’s drawn significant investment in recent years.
World Pharma News
AUGUST 5, 2024
Northwestern University scientists have developed a new bioactive material that successfully regenerated high-quality cartilage in the knee joints of a large-animal model. Although it looks like a rubbery goo, the material is actually a complex network of molecular components, which work together to mimic cartilage's natural environment in the body.
BioPharma Dive
AUGUST 5, 2024
All doses of the in-demand GLP-1 medicines are now available in the U.S., Lilly said ahead of reporting second quarter earnings later this week.
Expert insights. Personalized for you.
363 
Let's personalize your content